Home
Sanofi

Sanofi Market Share Analysis for November 2025

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo.

Health > Biotechnology and Pharmaceuticals

Domainsanofi.at

Year Founded1973

Employees> 10001

Annual Revenue> $1B

Sanofi

Sanofi (including company regionals)

sanofi.at

See more website traffic and engagement information

Sanofi Revenue up to November 2025 is > 1B

revenue generated by Sanofi top domains

Sanofi top domains revenue over 3 years

Revenue for Sanofi top domains

sanofi.at> 1B

See more with Sales Intelligence

Sanofi Stock price in November 2025

Sanofi stock is traded under the ticker #SNY. Below you can review Sanofi stock performance in the past 12 months up to November 2025

Total visits to Sanofi's top domains

Understand Sanofi market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Sanofi's top domains

Analyze Sanofi engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Sanofi's top domains

See how Sanofi keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Sanofi top competitors by domain

Top similar sites in November 2025, ranked by their affinity

astrazeneca.comCompany NameAstraZenecaEmployees> 10001HQUnited Kingdom, CambridgeAnnual revenue> $1BTotal visits1.5MHealth > Biotechnology and Pharmaceuticals

Top technologies used by Sanofi

These are the website technologies, by industry, used by Sanofi top domains

Payment & Currencies (22)

PayPal

Audio Video Media (3)

YouTube

Conversion & Analytics (3)

Google Analytics

Mobile (3)

Meta Viewport

More Technologies

8

See all

News & Signals from Sanofi

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSanofi acquired Origimm on Dec 1st '21.Sanofi has signed an agreement to buy Origimm Biotechnology, an Austria-based privately owned biotechnology company with focus on virulent skin microbiome components and antigens from bacteria causing skin disease.